Clinical Trial Update: An Interventional Study for Patient With Cancer Pain to Evaluate the Efficacy and Safety of OxyNorm® Compared to Morphine Sulfate Through the IV Continuous Infusion. [Phase 4]

View source ↗

Summary

A Phase 4 interventional trial comparing OxyNorm to morphine sulfate via IV infusion in cancer pain patients has completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Pain

Drugs mentioned

• MORPHINE SULFATE (MORPHINE SULFATE)
• OxyNorm (oxycodone)

Snippet

Sponsor: Mundipharma Korea Ltd | Conditions: Cancer Pain | Phase 4 | Status: COMPLETED | Results posted: 2018-11-19